Categories & Topics

Categories

  1. Hypertension for SDGs Toward 2030 World
  2. Global Health and Hypertension With Diversity (Racial, Economical difference, Medical resources)
  3. Life-course and Hypertension (Preconception, DOHaD, cancer and hypertension)
  4. Three Main Topics: Hypertension and AI/Dx, Hypertension and FOOD/Nutrition, Hypertension and Physical Fitness
  5. Super-aged Society and Hypertension (Sarcopenia, Dementia, Social Capitals etc.)
  6. Hypertension Next Generation therapy (Renal Denervation, Single compound pills, Application)
  7. Convergence of Communicable Diseases (Infectious diseases) and NCDs
  8. Novel strategy to conquer hypertension
  9. Pathophysiology of Hypertension: Chronicle to the Future
  10. Blood Pressure Measurement: Conventional and Future
  11. Imaging and Biomarker for Hypertension Management
  12. Hypertension Reigning Over Systemic Diseases
  13. Genetics, epigenetics, and microRNAs in blood pressure regulation

Topics

  1. Aging
  2. Alcohol, Drinking
  3. Animal Models
  4. Antihypertensive Drug Therapy
  5. Arrhythmias
  6. Arterial Compliance
  7. Artificial Intelligence
  8. Atherosclerosis
  9. Atrial Fibrillation
  10. Automated Office Blood Pressure
  11. Big Data, Precision Medicine, Artificial Intelligence, Machine Learning
  12. Biomarkers
  13. Blood Pressure Measurement
  14. Blood Pressure Variability
  15. Cardiac Function
  16. Cardiac Hypertrophy
  17. Cardiovascular Complications
  18. Children and Adolescents, Pediatric Hypertension
  19. Cholesterol
  20. Climate Change
  21. Clinical Inertia
  22. Coagulation and Thrombosis
  23. Cognitive Dysfunction
  24. Co-Morbidities
  25. Coronary Heart Disease
  26. COVID-19 and ACE2
  27. COVID-19 and Cardiovascular Disease
  28. COVID-19 and Hypertension
  29. COVID-19 and RAAS Inhibition
  30. Dental Health
  31. Detection and Control
  32. Diabetes
  33. Dialysis
  34. Diet
  35. Digital Device
  36. Disaster Hypertension
  37. Diversity in Hypertension-Related Diseases
  38. Echocardiography
  39. eHealth and ICT
  40. Electrolytes
  41. Endocrine Hypertension
  42. Endocrinology
  43. Endothelium
  44. Environmental Factors
  45. Epidemiology
  46. Ethnicity
  47. Exercise
  48. Experimental Hypertension
  49. Food
  50. Frailty
  51. Gender
  52. Generation and Life Course Factors
  53. Genetics, Genomics, Proteomics, Metabolomics
  54. Global Burden of Hypertension
  55. Global CVD Prevention
  56. Guidelines
  57. Heart and Haemodynamics
  58. Heart Failure
  59. Heart Rate, Pulse Rate
  60. High Altitude
  61. Hormones
  62. Hypotension
  63. Imaging in Hypertension
  64. Inflammation and Immunity
  65. Inter-Organ Communication
  66. Interventional Therapy and Devices
  67. Kidney
  68. Large Arteries
  69. Life-Style Changes, Modifications
  70. Lipids, Lipoproteins
  71. Malignant Hypertension
  72. Masked Hypertension
  73. Meta-Analysis
  74. Metabolic Syndrome, Metabolic Disorders
  75. Microbiota
  76. Microcirculation/Small Vessels
  77. Models, Statistics
  78. Multidisciplinary Approach
  79. New Devices and Therapeutics
  80. Non-Pharmacological Treatment
  81. Nutrition, Food
  82. Obesity
  83. Occupational Health
  84. Onco-Hypertension, Onco-Cardiology, Onco-Nnephrology
  85. Oriental Medicine, Herbal Medicine
  86. Pharmacology
  87. Plumonary Hypertension
  88. Preemptive Medicine
  89. Pregnancy, Hypertensive Disorders of Pregnancy and Preeclampsia
  90. Preventive Medicine
  91. Primary Care/Family Medicine
  92. Psychological Approach
  93. Public Health
  94. Quality of Life, Well-Being
  95. Renin-Angiotensin-Aldosterone System
  96. Resistant Hypertension
  97. Risk Factors
  98. Salt
  99. Salt Reduction, Dash, and Healthy Diet
  100. Sarcopenia
  101. Secondary Hypertension
  102. Sleep Apnea and Neural Mechanisms
  103. Smoking, Tobacco
  104. Socioeconomic Status, Social Capital
  105. Sport
  106. Stress
  107. Stroke, Cerebrovascular Diseases
  108. Sustainable Developmental Goal and Hypertension
  109. Sympathetic Nervous System
  110. Therapeutics and Clinical Trials
  111. Treatment Adherence
  112. Treatment Target in Hypertension
  113. Uric Acid
  114. Vasculature and Lymphatic Vessels
  115. White-Coat Hypertension
back to top